Latanoprostene Bunod
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB11660 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 54 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | visceral calciphylaxis | KG + DL |
| 2 | primary hereditary glaucoma | KG + DL |
| 3 | venous thoracic outlet syndrome | KG + DL |
| 4 | arterial thoracic outlet syndrome | KG + DL |
| 5 | neurogenic thoracic outlet syndrome | KG + DL |
| 6 | vascular disease | KG + DL |
| 7 | idiopathic spontaneous coronary artery dissection | KG + DL |
| 8 | angiodysplasia of stomach | KG + DL |
| 9 | lymphangiectasis | KG + DL |
| 10 | hemangioendothelioma | KG + DL |
| 11 | blue toe syndrome | KG + DL |
| 12 | atheroembolism of kidney | KG + DL |
| 13 | arterial dissection-lentiginosis syndrome | KG + DL |
| 14 | glaucoma 1, open angle | KG + DL |
| 15 | respiratory failure | KG + DL |
| 16 | subarachnoid hemorrhage (disease) | KG + DL |
| 17 | tinea nigra | KG + DL |
| 18 | open angle glaucoma | KG + DL |
| 19 | hypotrichosis-lymphedema-telangiectasia syndrome (grouping) | KG + DL |
| 20 | chylous ascites | KG + DL |
| 21 | mullerian derivatives-lymphangiectasia-polydactyly syndrome | KG + DL |
| 22 | lymphedema-cerebral arteriovenous anomaly syndrome | KG + DL |
| 23 | microcephaly with or without chorioretinopathy, lymphedema, or intellectual disability | KG + DL |
| 24 | lymphedema-atrial septal defects-facial changes syndrome | KG + DL |
| 25 | German syndrome | KG + DL |
| 26 | podoconiosis | KG + DL |
| 27 | congestive heart failure | KG + DL |
| 28 | acute pulmonary heart disease | KG + DL |
| 29 | Moyomoya angiopathy | KG + DL |
| 30 | hepatic porphyria | KG + DL |
| 31 | idiopathic macular telangiectasia | KG + DL |
| 32 | vasoproliferative tumor of retina | KG + DL |
| 33 | dermatophytosis | KG + DL |
| 34 | primitive portal vein thrombosis | KG + DL |
| 35 | hepatoportal sclerosis | KG + DL |
| 36 | idiopathic copper-associated cirrhosis | KG + DL |
| 37 | early-onset familial noncirrhotic portal hypertension | KG + DL |
| 38 | hepatopulmonary syndrome | KG + DL |
| 39 | non-syndromic esophageal malformation | KG + DL |
| 40 | acquired aneurysmal subarachnoid hemorrhage | KG + DL |
| 41 | androgen insensitivity syndrome | KG + DL |
| 42 | benign choroid plexus neoplasm | KG + DL |
| 43 | IRVAN syndrome | KG + DL |
| 44 | cerebral visual impairment | KG + DL |
| 45 | neonatal respiratory failure | KG + DL |
| 46 | biotin metabolic disease | KG + DL |
| 47 | homozygous familial hypercholesterolemia | KG + DL |
| 48 | glaucoma | KG + DL |
| 49 | esophageal disease | KG + DL |
| 50 | vitamin deficiency disorder | KG + DL |
(Showing top 50 of 54 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.